Avalon Pharma gets nod from SFDA to register new production lines

06/05/2024 Argaam
Logo ofMiddle East Pharmaceutical Industries company(AvalonPharma)

Logo of Middle East Pharmaceutical Industries company (Avalon Pharma)

Middle East Pharmaceutical Industries Co. (Avalon Pharma) obtained the approval of the Saudi Food and Drug Authority (SFDA) to register new production lines at factory No. 2 in Riyadh.

 

The new production lines are for capsules and tablets, in addition to semi-solid materials including creams, ointments, and gels, Avalon Pharma said in a statement to Tadawul.

 

When fully operational, the new lines will have a manufacturing and production capacity of 270 million tablets and capsules annually, while the production and manufacturing capacity for semi-solid materials will reach 22 million units annually.

 

The company explained that commercial production on the newly registered production lines will commence upon obtaining approvals from SFDA.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.